1. Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts
- Author
-
Aline Nogueira Olive, Valdemir Melechco Carvalho, Maria Carolina Pintao, Carolina S. Lazari, Luciana Godoy Viana, Karina Helena Morais Cardozo, Rodrigo Andrade Schuch, Ana Maria Fraga, Guilherme Goncalves Okai, Celso Francisco Hernandes Granato, and Adriana Lebkuchen
- Subjects
Proteomics ,0301 basic medicine ,Science ,Sample (material) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Large population ,Proteomic analysis ,Oropharynx ,General Physics and Astronomy ,Computational biology ,Sensitivity and Specificity ,01 natural sciences ,Rapid detection ,Article ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,COVID-19 Testing ,Nasopharynx ,Humans ,Medicine ,Multidisciplinary ,Mass spectrometry ,SARS-CoV-2 ,Clinical Laboratory Techniques ,business.industry ,010401 analytical chemistry ,General Chemistry ,Viral proteins ,Sample stability ,0104 chemical sciences ,Targeted proteomics ,030104 developmental biology ,Fully automated ,Viral infection ,business - Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pressing public health systems around the world, and large population testing is a key step to control this pandemic disease. Here, we develop a high-throughput targeted proteomics assay to detect SARS-CoV-2 nucleoprotein peptides directly from nasopharyngeal and oropharyngeal swabs. A modified magnetic particle-based proteomics approach implemented on a robotic liquid handler enables fully automated preparation of 96 samples within 4 hours. A TFC-MS system allows multiplexed analysis of 4 samples within 10 min, enabling the processing of more than 500 samples per day. We validate this method qualitatively (Tier 3) and quantitatively (Tier 1) using 985 specimens previously analyzed by real-time RT-PCR, and detect up to 84% of the positive cases with up to 97% specificity. The presented strategy has high sample stability and should be considered as an option for SARS-CoV-2 testing in large populations., Large population testing is a key step to controlling the COVID-19 pandemic. Here, the authors develop a targeted mass spectrometry system for peptide-based SARS-CoV-2 detection, allowing analysis of over 500 swab samples per day and enabling virus detection even after prolonged sample storage at room temperature.
- Published
- 2020
- Full Text
- View/download PDF